Complementary and alternative treatments for autism part 1: evidence-supported treatments

AMA J Ethics. 2015 Apr 1;17(4):369-74. doi: 10.1001/journalofethics.2015.17.4.sect1-1504.

Authors

Stephen Bent¹, Robert L Hendren²

Affiliations

¹ Associate professor of medicine, psychiatry, and epidemiology and biostatistics at the University of California, San Francisco, School of Medicine.
² Professor of psychiatry and behavioral science, the director of child and adolescent psychiatry, and vice chair of the Department of Psychiatry at the University of California, San Francisco, School of Medicine.

PMID: 25901707
DOI: 10.1001/journalofethics.2015.17.4.sect1-1504

No abstract available

Publication types

Review

MeSH terms

Acetylcysteine / therapeutic use*
Animals
Antipsychotic Agents / therapeutic use*
Aripiprazole / therapeutic use
Autistic Disorder / drug therapy
Autistic Disorder / metabolism*
Autistic Disorder / psychology
Autistic Disorder / therapy*
Complementary Therapies / methods*
Disease Models, Animal
Evidence-Based Medicine
Free Radical Scavengers / therapeutic use
Gastrointestinal Tract / drug effects
Gastrointestinal Tract / metabolism*
Humans
Inflammation / drug therapy
Inflammation / metabolism
Mice
Oxidative Stress / drug effects*
Randomized Controlled Trials as Topic
Risperidone / therapeutic use
United States
United States Food and Drug Administration
Vitamin B 12 / analogs & derivatives*
Vitamin B 12 / therapeutic use

Substances

Antipsychotic Agents
Free Radical Scavengers
Aripiprazole
mecobalamin
Risperidone
Vitamin B 12
Acetylcysteine